1-(2-Deoxy-2-fluoro-beta-D-ribofuranosyl)tetrahydro-2(1H)-pyrimidinone

ID: ALA3237554

PubChem CID: 57704512

Max Phase: Preclinical

Molecular Formula: C9H15FN2O4

Molecular Weight: 234.23

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1NCCCN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1F

Standard InChI:  InChI=1S/C9H15FN2O4/c10-6-7(14)5(4-13)16-8(6)12-3-1-2-11-9(12)15/h5-8,13-14H,1-4H2,(H,11,15)/t5-,6-,7-,8-/m1/s1

Standard InChI Key:  DINLEAHFNSLTEA-WCTZXXKLSA-N

Molfile:  

     RDKit          2D

 16 17  0  0  0  0  0  0  0  0999 V2000
   12.4113  -21.1904    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8935  -20.5316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7187  -20.5316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6497  -19.7450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9662  -19.7249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3209  -19.2547    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.8657  -19.4894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8454  -18.6717    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7541  -19.4685    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4646  -19.8842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1884  -19.4720    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1895  -18.6465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4747  -18.2315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7591  -18.6420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2056  -21.1941    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.4667  -20.7049    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  2  4  1  0
  3  5  1  0
  4  6  1  0
  5  6  1  0
  2  1  1  6
  7  8  1  0
  4  7  1  1
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  9  1  0
  5  9  1  1
  3 15  1  6
 10 16  2  0
M  END

Associated Targets(Human)

CDA Tclin Cytidine deaminase (97 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 234.23Molecular Weight (Monoisotopic): 234.1016AlogP: -1.18#Rotatable Bonds: 2
Polar Surface Area: 82.03Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.66CX Basic pKa: CX LogP: -1.70CX LogD: -1.70
Aromatic Rings: Heavy Atoms: 16QED Weighted: 0.56Np Likeness Score: 1.08

References

1. Ferraris D, Duvall B, Delahanty G, Mistry B, Alt J, Rojas C, Rowbottom C, Sanders K, Schuck E, Huang KC, Redkar S, Slusher BB, Tsukamoto T..  (2014)  Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase.,  57  (6): [PMID:24520856] [10.1021/jm401856k]

Source